ONCY News and Press, Oncolytics Biotech Inc. From 12/08/22

Oncolytics Biotech's® Chinese Development Partner Adlai Nortye Presents Interim Clinical Data Further Demonstrating the Anti-Cancer Activity of Pelareorep-Paclitaxel Combination Therapy in HR+/HER2- Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium PR Newswire ...

Palm Beach, FL – December 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Global Market Insights the Breast Cancer Therapeutics Market size, which exceeded USD 25.5 billion in 2021, is estimated to register around 8% CAGR betw...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 1, 2022 – USA News Group –  A series of new Fast Track designations have been handed out by the United States Food and Drug Administration (FDA) this week, causing a flurry...

Palm Beach, FL – December 1, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer accounts for over 3% of all types of cancers in US. A lethal type of cancer, pancreatic cancer starts in the pancreas of the human body when abnormal cells in the pancre...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 30, 2022 – USA News Group –  A new study has revealed that women diagnosed with benign breast disease through screening have an almost double risk of acquiring breast cance...

Oncolytics Biotech® Announces Presentations at the Upcoming San Antonio Breast Cancer Symposium Canada NewsWire SAN DIEGO and CALGARY, AB , Nov. 21, 2022 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced th...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 15, 2022 – USA News Group –  Roughly five years after selling its flagship cancer asset Onivyde from to French biotech giant Ipsen S.A. for approximately $1 billi...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 14, 2022 – USA News Group –  English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his victory over pancreatic cancer, known as t...

Palm Beach, FL – November 10, 2022 – FinancialNewsMedia.com News Commentary – The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market competition, the market participants are implementing methods including increased ...

Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort Canada NewsWire One complete response (CR) and eight partial responses (PR) a...